Skip to main content
. 2012 Jul 11;4(4):637–641. doi: 10.3892/ol.2012.796

Table II.

Change in serum ERC/mesothelin levels in serous adenocarcinoma.

Marker Prior to surgery or chemotherapy Following surgery or chemotherapy 6 months after chemotherapy Following 4 cycles of chemotherapy
N(7-4), ng/ml 4.76 2.00 3.33 5.00
N(7-16), ng/ml 18.67 2.50 9.95 26.80
CA125, U/ml 577.3 5.2 108.5 303.7